BioSecure Act Ramifications – Treehill CEO feature in GlobalData article

BioSecure Act Ramifications – Treehill CEO feature in GlobalData article

Clinical Trials Arena, a leading flagship GlobalData publication has a headline article today about the BioSecure Act and its potential effects on the drug development space in the US and internationally. Ali Pashazadeh, Treehill Partners CEO, provides a healthy and much needed dose of realism to the issue. 

Read on here:

https://www.clinicaltrialsarena.com/features/biosecure-companies-turning-united-states-manufacturing/

Subscribe to our mailings!

Thank You

Please choose your subscriptions:

Unsubscribe any time using the footer of our emails. For information about our privacy practices, please visit our privacy policy.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.